H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease

World Journal of Gastroenterology

Volumn 12, Issue 48, 2006, Pages 7815-7820

  Lenzi, Cristina ^a   Palazzuoli, Alberto ^a   Giordano, Nicola ^a   Alegente, Giuliano ^b   Gonnelli, Catia ^a   Campagna, Maria Stella ^a   Santucci, Annalisa ^a   Sozzi, Michele ^c   Papakostas, Panagiotis ^a   Rollo, Fabio ^a   Nuti, Ranuccio ^a   Figura, Natale ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c General Hospital   (Italy)

Author keywords

Antibody response; CagA protein; Coronary heart disease; H pylori; Heat shock protein 60

Indexed keywords

BACTERIUM ANTIBODY; CAGA PROTEIN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN G ANTIBODY; POLYCLONAL ANTIBODY; POLYSTYRENE;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOPATHOGENESIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PREVALENCE; RISK FACTOR; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 33846254866     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i48.7815     Document Type: Article

References (30)

1. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998; 97: 1675-1679
2. Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84: 267-271
3. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100: e20-e28
4. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 2002; 90: 2-4
5. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-625
6. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 1993; 22: 89-104
7. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176
8. Graham DY, Osato MS, Olson CA, Zhang J, Figura N. Effect of H pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H pylori infection. Helicobacter 1998; 3: 174-178
9. Perri F, Clemente R, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M, Grossi E, Andriulli A. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol 1999; 31:290-294
10. Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ 1994; 309: 1119-1123
11. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-439
12. Ossei-Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon AT, Grant PJ. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 1997; 35: 120-124
13. Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton J. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000; 101: 1647-1652
14. Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R, Kranig W, Nassed R, Thale J, Hahn EG, Konturek SJ. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001; 33: 222-229
15. Prohaszka Z, Duba J, Horvath L, Csaszar A, Karadi I, Szebeni A, Singh M, Fekete B, Romics L, Fust G. Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest 2001; 31: 285-292
16. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet 1988; 22: 631-677
17. Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 1996; 2: 372-379
18. Winfield JB, Jarjour WN. Stress proteins, autoimmunity, and autoimmune disease. Curr Top Microbiol Immunol 1991; 167: 161-189
19. Fayet O, Ziegelhoffer T, Georgopoulos C. The groES and groEL heat shock gene products of Escherichia coli are essential for bacterial growth at all temperatures. J Bacteriol 1989; 171: 1379-1385
20. Suerbaum S, Thiberge JM, Kansau I, Ferrero RL, Labigne A. Helicobacter pylori hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity. Mol Microbiol 1994; 14: 959-974
21. Perez-Perez GI, Thiberge JM, Labigne A, Blaser MJ. Relationship of immune response to heat-shock protein A and characteristics of Helicobacter pylori-infected patients. J Infect Dis 1996; 174: 1046-1050
22. Ossei-Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon AT, Grant PJ. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 1997; 35: 120-124
23. Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton J. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000; 101: 1647-1652
24. Lamb DJ, El-Sankary W, Ferns GA. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 2003; 167: 177-185
25. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-14653
26. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-98
27. Figura N, Palazzuoli A, Faglia S, Lenzi C, Borrello F, Palazzuoli V, Nami R, Dal Canto N, De Regis F, Vaira D, Gennari L, Giordano N, Gennari C. Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities. Dig Dis Sci 2002; 47: 831-836
28. Iaquinto G, Todisco A, Giardullo N, D'Onofrio V, Pasquale L, De Luca A, Andriulli A, Perri F, Rega C, De Chiara G, Landi M, Taccone W, Leandro G, Figura N. Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis 2000; 32: 378-383
29. Wick G, Knoflach M, Kind M, Henderson B, Bernhard D. Heat shock proteins and stress in atherosclerosis. Autoimmun Rev 2004; 3 Suppl 1: S30-S31
30. Latif N, Taylor PM, Khan MA, Yacoub MH, Dunn MJ. The expression of heat shock protein 60 in patients with dilated cardiomyopathy. Basic Res Cardiol 1999; 94: 112-119